Loyola University Of Chicago

Loyola University of Chicago Health Sciences Campus Division, operating as Health Sciences Campus, is a tax-exempt, non-profit academic medical center division delivering organ transplant services and clinical research to the Department of Veterans Affairs as a prime contractor and federal grant recipient. The division operates as part of the parent Loyola University of Chicago, a private Jesuit Catholic research institution headquartered in Chicago with the Health Sciences Campus located in Maywood, Illinois.

The Health Sciences Campus competes in full-and-open (non-set-aside) procurement and generates its federal revenue primarily through single-award indefinite delivery contracts with the VA and project grants from the National Institutes of Health and other civilian agencies. The division does not operate as a subcontractor to other federal primes; across recent awards, 84% are prime awards (contracts, IDVs, and grants) and 16% are sub-awards, reflecting a institutional posture of direct prime contracting for specialized medical services and research.

Concrete capability centers on live donor kidney transplant surgery, nephrology care, and evaluation services for veterans. The division has held six active single-award IDVs with the VA's Veterans Integrated Service Networks 12 and 4 since 2022, with the largest valued at $963,520 (running through August 2027) supporting long-term live donor kidney transplant and nephrology services at Edward Hines Jr. VA Hospital. Recent delivery orders under these vehicles range from $2,300 to $27,467.53 and cover kidney transplant evaluations, surgical procedures, post-operative care, and single-case organ removal services. Beyond transplant work, the division has delivered T-cell manufacturing for the National Heart Lung and Blood Institute (Protocol 18-H-0012, $250,000 award, May 2025) and sepsis biomarker support services for the Defense Health Agency ($351,907.04 ceiling, April 2025).

The division's grant portfolio reflects a research-intensive institution. Recent federal grant prime awards include $1.696 million from the Defense Health Agency (Military Medical Research and Development program, September 2026) for studying angiopoietin-1 mimetic peptides in burn shock treatment; $847,000 from the National Institute of General Medical Sciences (August 2025) for burn sepsis prognostic strategies; $781,718 from NIAID (June 2025) for a novel T cell-based dengue and Zika vaccine; $774,361 from the National Institute of Neurological Disorders and Stroke (August 2025) for Rett Syndrome oligonucleotide therapeutics; and $689,428 from the National Institute of Child Health and Human Development (June 2026) for family assessment in youth with spina bifida. The division also received $1.896 million from the Bureau of Health Professionals (Nurse Education, Practice, Quality and Retention program, September 2025) for rural healthcare nursing scholar pipeline development. These grants evidence capability in biomedical research spanning immunology, cardiovascular disease, infectious disease, oncology, neurodevelopmental disorders, and nursing workforce development.

Customer concentration is stark. The Department of Veterans Affairs Veterans Integrated Service Network 12 dominates the award portfolio with 118 awards valued at $5.5 million combined potential value—representing 20% of total awards and 66% of total potential value across the division. This concentration reflects the long-standing relationship for transplant services at Hines VA Hospital. The National Institutes of Health and component institutes (NIAID, National Heart Lung and Blood Institute, National Cancer Institute, National Institute of General Medical Sciences, and others) account for the second and third tiers of activity through discretionary research grant awards, with 116+ awards across NIH as a whole. The Defense Health Agency, National Institute of Allergy and Infectious Diseases, and National Cancer Institute rank as additional active grantors. The division serves 51 distinct federal agencies, but the top five account for approximately 59% of awards.

Recent activity shows stable to modest growth. Awards per year ranged from 45–66 over the past five years (2022–2026), with 63 awards in 2025 and 35 through the current year (2026) as of the source date. Over 69 awards ($165 thousand combined potential value) reach ultimate completion within the next twenty-four months, presenting recompete exposure concentrated in VA delivery order renewals.

The division subcontracts on federal research grants as a sub-recipient to prime grantee institutions, including Northwestern University, the University of Chicago, the University of Pennsylvania, Indiana University Indianapolis, and the University of Colorado. Sub-award roles include providing microbiology and genomics analysis, biostatistical consultation, mass spectrometry services, clinical trial recruitment and operations support, and research coordination across cancer, infectious disease, neurology, and translational medicine domains. This sub-recipient activity represents collaborative research participation rather than dependent subcontracting; the division maintains independent prime capacity across both contract and grant vehicles.

Service Contract Inventory data covering federal services contracts above the $150,000 threshold shows limited SCI-reportable volume: $757 thousand invoiced across FY2022–FY2024 (FY2022: $412 thousand; FY2024: $345 thousand). Government-paid hourly rates on SCI-reportable work ranged from a 10th percentile of $174.60/hr to a 90th percentile of $232.27/hr, with a median of $203.43/hr. The low SCI footprint reflects the division's primary revenue model: surgical service delivery and research grants (which carry different reporting thresholds) rather than labor-intensive federal services contracts.